184 related articles for article (PubMed ID: 37823964)
1. Novel radionuclides for use in Nuclear Medicine in Europe: where do we stand and where do we go?
Radzina M; Saule L; Mamis E; Koester U; Cocolios TE; Pajuste E; Kalnina M; Palskis K; Sawitzki Z; Talip Z; Jensen M; Duchemin C; Leufgen K; Stora T
EJNMMI Radiopharm Chem; 2023 Oct; 8(1):27. PubMed ID: 37823964
[TBL] [Abstract][Full Text] [Related]
2. Scandium and terbium radionuclides for radiotheranostics: current state of development towards clinical application.
Müller C; Domnanich KA; Umbricht CA; van der Meulen NP
Br J Radiol; 2018 Nov; 91(1091):20180074. PubMed ID: 29658792
[TBL] [Abstract][Full Text] [Related]
3. ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine.
Haddad F; Ferrer L; Guertin A; Carlier T; Michel N; Barbet J; Chatal JF
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1377-87. PubMed ID: 18465127
[TBL] [Abstract][Full Text] [Related]
4. Development of novel radionuclides for medical applications.
Qaim SM; Spahn I
J Labelled Comp Radiopharm; 2018 Mar; 61(3):126-140. PubMed ID: 29110328
[TBL] [Abstract][Full Text] [Related]
5. Emerging Radionuclides in a Regulatory Framework for Medicinal Products - How Do They Fit?
Decristoforo C; Neels O; Patt M
Front Med (Lausanne); 2021; 8():678452. PubMed ID: 34124109
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Nuclear data for production and medical application of radionuclides: Present status and future needs.
Qaim SM
Nucl Med Biol; 2017 Jan; 44():31-49. PubMed ID: 27821344
[TBL] [Abstract][Full Text] [Related]
8. 3p-C-NETA: A versatile and effective chelator for development of Al
Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
[No Abstract] [Full Text] [Related]
9. Neutron-activated theranostic radionuclides for nuclear medicine.
Tan HY; Yeong CH; Wong YH; McKenzie M; Kasbollah A; Md Shah MN; Perkins AC
Nucl Med Biol; 2020; 90-91():55-68. PubMed ID: 33039974
[TBL] [Abstract][Full Text] [Related]
10. Radiation safety of current European practices of therapeutic nuclear medicine: survey results from 20 HERCA countries.
Bly R
J Radiol Prot; 2023 Jan; 43(1):. PubMed ID: 36599154
[TBL] [Abstract][Full Text] [Related]
11. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Positron Range on PET Resolution, Evaluated with Phantoms and PHITS Monte Carlo Simulations for Conventional and Non-conventional Radionuclides.
Carter LM; Kesner AL; Pratt EC; Sanders VA; Massicano AVF; Cutler CS; Lapi SE; Lewis JS
Mol Imaging Biol; 2020 Feb; 22(1):73-84. PubMed ID: 31001765
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic radionuclides: production and decay property considerations.
Volkert WA; Goeckeler WF; Ehrhardt GJ; Ketring AR
J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
[TBL] [Abstract][Full Text] [Related]
15. Is there life after technetium: what is the potential for developing new broad-based radionuclides?
Srivastava SC
Semin Nucl Med; 1996 Apr; 26(2):119-31. PubMed ID: 8723506
[TBL] [Abstract][Full Text] [Related]
16. Cerenkov luminescence imaging of medical isotopes.
Ruggiero A; Holland JP; Lewis JS; Grimm J
J Nucl Med; 2010 Jul; 51(7):1123-30. PubMed ID: 20554722
[TBL] [Abstract][Full Text] [Related]
17. Radiation Safety Considerations and Clinical Advantages of α-Emitting Therapy Radionuclides.
Serencsits B; Chu BP; Pandit-Taskar N; McDevitt MR; Dauer LT
J Nucl Med Technol; 2022 Mar; 50(1):10-16. PubMed ID: 34750237
[No Abstract] [Full Text] [Related]
18. Current Status of Nuclear Medicine Practice in the Middle East.
Paez D; Becic T; Bhonsle U; Jalilian AR; Nuñez-Miller R; Osso JA
Semin Nucl Med; 2016 Jul; 46(4):265-72. PubMed ID: 27237437
[TBL] [Abstract][Full Text] [Related]
19. Main challenges in radiation protection with emerging radionuclide therapies.
Cunha L; Baete K; Leijen C; Jamar F
Q J Nucl Med Mol Imaging; 2023 Mar; 67(1):14-28. PubMed ID: 36598760
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer.
Alati S; Singh R; Pomper MG; Rowe SP; Banerjee SR
Semin Nucl Med; 2023 Sep; 53(5):663-686. PubMed ID: 37468417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
